Open Nav

Please submit your session questions in advance at

Femeda Ltd

  • Andrew Tasker, Femeda Ltd

Femeda is a UK based healthcare company focused on the development an innovative female health portfolio.

With its specialism in female health, it has recently launched its first product Pelviva, a treatment for female urinary incontinence in the UK. Pelviva is a new and unique disposable, clinically effective, discreet and easy-to-use Pelvic Floor muscle re-trainer which treats urinary incontinence in women, demonstrating proven clinical success.

Pelviva addresses THE biggest unmet need in female health. The unique development is the result of combining advanced research and patents from University of Manchester with Femeda product development expertise to deliver a product which meets core patient needs.

A third of all women suffer from bladder leakage and Pelviva is the first product of its kind that is really easy to use and is clinically proven to treat bladder leaks. Pelviva is a pioneering medical device that will have a life-changing impact on women’s quality of life.

  • Date:Monday, February 11
  • Time:10:30 AM - 10:45 AM
  • Room:Chelsea
  • Location:7th Floor
  • Session Type:Company Presentation
  • Submission ID:23517
  • Company Presentation - Presentation Type:Privately Funded Company
  • Goal for Presentation:Platform for commencing regional licensing deals/US partner
  • Company
  • Company HQ City:Cramlington, NE23 1WD
  • Company HQ Country:United Kingdom
  • Total Amount Raised to Date, in All Rounds:£15.5million
  • Size of Last Investment Round:£4 million
  • Previous and Current Investors:Northstar, Mercia, Hotspur, Management
  • CEO/Top Company Official:Andrew Tasker
  • Year Founded:2010
  • Main Therapeutic Focus:Medical Devices
  • Lead Product in Development:Pelviva
  • Development Phase of Primary Product:Multiple Products in Market
  • Number Of Unlicensed Products (For Which You Are Seeking Partners):Two
  • Additional Information/Comments:Femeda have launched Pelviva in the UK market and wish to commence outlicencing discussions, whilst also searching for broader development and product opportunities in the female health area, to pursue its vision of establishing a leadership female health focused business.
Andrew Tasker
Femeda Ltd